Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
Shigeru Toyoda, Keisuke Kida, Atsushi Tanaka, Hisako Yoshida et al.
Journal
Cardiovascular Diabetology
Topics
Hormonal Regulation and Hypertension
article
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
Brigham and Women's Hospital (US), Toho University (JP), Fukushima Medical University (JP), Harvard University (US), Okayama University (JP), St. Marianna University School of Medicine (JP), Saga University (JP), University of Occupational and Environmental Health Japan (JP), Oita University (JP), Kobe University Hospital (JP), Toho University Ohashi Medical Center (JP), Hiroshima General Hospital (JP), Mitsui Memorial Hospital (JP), Juntendo University Shizuoka Hospital (JP), Dokkyo Medical University Saitama Medical Center (JP), Japan Clinical Cancer Research Organization (JP), Social Insurance Saitama Chuo Hospital (JP), Osaka Metropolitan University (JP), Tokyo Metropolitan University (JP), The University of Tokyo (JP), Dokkyo Medical University (JP)